Qlosi Aspen Pharmacare Australia Pty Ltd
Product name
Qlosi
Accepted date
Jun-2026
Active ingredients
pilocarpine hydrochloride
Summary of proposed indication
QLOSI (pilocarpine HCL) is proposed for the treatment of presbyopia in adults, the age-related loss of the eyes' ability to focus on nearby objects.
Application type
C (new indication)
Publication date
Jun-2026